Xact Kapitalforvaltning’s Integra LifeSciences IART Stock Holding History

Xact Kapitalforvaltning’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$590K	Hold	13,202	–	–	0.01%	680
2019 Q4	$769K	Hold	13,202	–	–	0.01%	743
2019 Q3	$793K	Hold	13,202	–	–	0.02%	674
2019 Q2	$737K	Hold	13,202	–	–	0.02%	705
2019 Q1	$736K	Hold	13,202	–	–	0.02%	706
2018 Q4	$595K	Hold	13,202	–	–	0.02%	769
2018 Q3	$870K	Buy	13,202 +4,000	+43%	+$249K	0.02%	646
2018 Q2	$593K	Hold	9,202	–	–	0.01%	818
2018 Q1	$509K	Buy	9,202 +2,700	+42%	+$142K	0.01%	821
2017 Q4	$311K	Buy	+6,502	New	+$318K	0.01%	927

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Xact Kapitalforvaltning's IART Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Integra LifeSciences (IART) position steady in Q1 2020 at 13,202 shares worth $590K. The position accounts for 0.01% of the portfolio, ranked #680.

Xact Kapitalforvaltning first reported a position in IART in Q4 2017 and has held it in 10 quarters since. The position peaked at $870K in Q3 2018. 258 funds tracked by Wall St. Rank hold IART as of Q1 2020.

Xact Kapitalforvaltning held 13,202 shares of Integra LifeSciences worth $590K as of Q1 2020.
Xact Kapitalforvaltning left its Integra LifeSciences share count unchanged in Q1 2020.
Integra LifeSciences made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #680 holding.
Xact Kapitalforvaltning first reported a position in Integra LifeSciences in Q4 2017 and has held it in 10 quarters since.
Xact Kapitalforvaltning's Integra LifeSciences position peaked at $870K in Q3 2018.
258 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.